These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6187047)

  • 1. Neurotransmitter functions in depression.
    Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):639-44. PubMed ID: 6187047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Critical view of biochemical factors in depressive syndromes and the prescription of antidepressants].
    Loo H; Zarifian E
    Ann Med Psychol (Paris); 1982 Feb; 140(2):240-51. PubMed ID: 6180668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Respective position of antidepressants in therapeutics (author's transl)].
    Moussaoui D
    Encephale; 1979; 5(5 Suppl):701-8. PubMed ID: 95010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites as predictors of antidepressant response: a critique.
    Kelwala S; Jones D; Sitaram N
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):229-40. PubMed ID: 6193563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Neuropsychobiology; 1982; 8(2):60-72. PubMed ID: 6175919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemistry of depression and antidepressants].
    Strolin Benedetti M
    Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical variables in subjects with adjustment disorder after suicide attempts.
    Tripodianakis J; Markianos M; Sarantidis D; Leotsakou C
    Eur Psychiatry; 2000 May; 15(3):190-5. PubMed ID: 10881216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic implications of the biochemical features about depressive illness (author's transl)].
    Lôo H
    Encephale; 1981; 7(4 Suppl):429-40. PubMed ID: 6172268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing the bipolar-unipolar dichotomy.
    Taylor MA; Abrams R
    J Affect Disord; 1980 Sep; 2(3):195-217. PubMed ID: 6176608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter hypotheses of depression. Research update.
    Jimerson DC
    Psychiatr Clin North Am; 1984 Sep; 7(3):563-73. PubMed ID: 6207513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
    Maas JW; Kocsis JH; Bowden CL; Davis JM; Redmond DE; Hanin I; Robins E
    Psychol Med; 1982 Feb; 12(1):37-43. PubMed ID: 6177015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
    Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
    Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
    Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.